SERPINE1 and primary cutaneous T-cell non-Hodgkin lymphoma: These studies suggested the contribution of PAI-1 in the disease progression of CTCL, leading to develop the PAI-1 targeting therapy for advanced CTCL, though there have been no reports in English that investigated the expression of PAI-1 in cutaneous T cell lymphoma.